Comprehensive Clinical Guide: Granular Myringitis

1. Introduction and Overview

Granular myringitis is a chronic, localized inflammatory condition of the tympanic membrane (TM) characterized by the formation of granulation tissue on its lateral surface. Unlike acute otitis media, which involves the middle ear cavity, or myringitis bullosa, which involves fluid-filled vesicles, granular myringitis is a surface pathology of the eardrum. It represents an epithelial migration failure or a chronic inflammatory response that results in the denudation of the squamous epithelium of the TM, leading to the exposure of the underlying fibrous layer and the subsequent development of granulation tissue.

Clinically, it presents as a persistent, often foul-smelling otorrhea, conductive hearing loss, and a sensation of fullness in the ear. It is frequently misdiagnosed as chronic suppurative otitis media (CSOM) or external otitis, leading to ineffective treatment cycles. Understanding its unique pathophysiology is essential for the clinician to avoid unnecessary surgical interventions and to implement targeted topical therapy.

2. Technical Specifications and Pathophysiology

The Mechanism of Epithelial Migration

The tympanic membrane possesses a unique self-cleaning mechanism known as epithelial migration. Squamous cells grow from the umbo outward toward the annulus and into the external auditory canal (EAC). When this process is interrupted—due to trauma, chronic infection, or iatrogenic injury—the epithelial layer is lost.

Pathophysiological Sequence

1. Denudation: The stratified squamous epithelium of the lateral TM is stripped away, exposing the lamina propria.
2. Inflammatory Response: The exposed subepithelial layer reacts to the environment of the ear canal. Bacteria (often Pseudomonas aeruginosa or Staphylococcus aureus) colonize the exposed fibrous layer.
3. Granulation Formation: In an attempt to heal, the body produces vascular, inflammatory granulation tissue. This tissue is friable and prone to bleeding.
4. Chronic Cycle: The granulation tissue interferes with the normal migration of epithelium, perpetuating a state of chronic inflammation and preventing re-epithelialization.

Histopathology

Microscopic examination of the granulation tissue reveals:
* Infiltration of polymorphonuclear leukocytes (PMNs).
* Hypervascularity (numerous capillary buds).
* Fibroblastic proliferation.
* Absence of a complete keratinizing squamous epithelial layer.

3. Clinical Indications, Presentation, and Staging

Standard Clinical Presentation

Patients typically present with symptoms that have persisted for weeks or months. Key indicators include:
* Otorrhea: Usually scant, purulent, or serosanguinous.
* Otalgia: Often mild or absent, unless secondary infection is severe.
* Hearing Loss: Conductive in nature, usually mild (10–30 dB), caused by the mass effect of the granulation tissue on the TM.
* Aural Fullness: A subjective feeling of pressure.

Clinical Staging/Grading (Proposed)

While there is no universally standardized staging system, clinicians often categorize the severity based on the extent of the TM involvement:

4. Diagnostic Approach and Differential Diagnosis

Key Diagnostic Tests

1. Otomicroscopy: The gold standard for diagnosis. It allows for high-magnification visualization to confirm that the granulation is attached to the TM and not the canal wall.
2. Culture and Sensitivity: Essential for selecting targeted topical antibiotics.
3. Audiometry: Pure-tone audiometry is required to quantify the conductive hearing loss.
4. CT Scan (Temporal Bone): Generally not required unless there is suspicion of cholesteatoma or middle ear involvement (mastoiditis).

Differential Diagnosis

It is critical to distinguish granular myringitis from other chronic ear conditions:

• Chronic Suppurative Otitis Media (CSOM): CSOM involves a TM perforation with middle ear mucosa inflammation. Granular myringitis has an intact TM, though it may appear thickened.
• Otitis Externa: Primarily involves the EAC. If the granulation is only on the TM, it is myringitis.
• Cholesteatoma: Presents as a white, keratinous mass. Granular myringitis is red and vascular.
• Glomus Tympanicum: A vascular tumor behind the TM. It appears as a pulsatile red mass but is covered by intact, thin epithelium.

5. Treatment Protocols

Conservative Management

1. Aural Toilet: Meticulous debridement of the ear canal and the TM surface using an operating microscope.
2. Topical Therapy: The use of antibiotic/corticosteroid drops (e.g., Ciprofloxacin/Dexamethasone).
3. Chemical Cautery: Silver nitrate (AgNO3) or trichloroacetic acid (TCA) application to the granulation tissue to encourage re-epithelialization. Caution: Must be performed by an otolaryngologist to prevent inner ear damage.

Surgical Intervention

Reserved for refractory cases:
* Myringoplasty: If the TM is severely scarred or if the defect refuses to heal, a graft may be necessary.
* Excision of Granulation: Surgical removal of the mass under general anesthesia if conservative measures fail after 3–6 months.

6. Risks, Contraindications, and Prognosis

Risks and Complications

• Iatrogenic Perforation: Over-zealous debridement or chemical cautery can cause a permanent TM perforation.
• Sensorineural Hearing Loss: Rare, but potential if caustic agents penetrate the middle ear.
• Chronic Stenosis: If the inflammatory process extends to the EAC, canal stenosis may occur.

Contraindications

• Ototoxic Drops: Avoid aminoglycosides (e.g., Gentamicin, Neomycin) if the TM integrity is questionable, although this is less of a concern in pure granular myringitis than in CSOM.

Long-term Prognosis

With proper care, the prognosis is excellent. Most cases resolve with regular debridement and topical therapy. However, recurrence is common if the patient has underlying Eustachian tube dysfunction or poor ear hygiene.

7. Frequently Asked Questions (FAQ)

1. Is granular myringitis contagious?
No, it is a localized inflammatory response and is not infectious in the traditional sense of spreading to others.

2. Does this condition cause permanent hearing loss?
Usually, the hearing loss is temporary and improves once the granulation tissue is removed and the TM heals. Permanent loss is rare unless complications like perforation occur.

3. Why do my drops stop working?
The granulation tissue acts as a physical barrier. If the ear is not cleaned under a microscope, the medicine cannot reach the underlying tissue.

4. Is surgery always required?
No. Surgery is a last resort. The vast majority of cases resolve with office-based debridement and topical drops.

5. How long does the healing process take?
Healing varies, but significant improvement is typically seen within 2–4 weeks of consistent treatment.

6. Can I swim with granular myringitis?
No. Water entry introduces bacteria and macerates the delicate, healing epithelium. Strict water precautions are mandatory.

7. Is the granulation tissue cancerous?
No, it is benign inflammatory tissue. However, any persistent growth should be biopsied if it does not respond to standard treatment to rule out rare malignancies.

8. What is the difference between this and a "fleshy" polyp?
A polyp is often a sign of deeper disease (like CSOM or cholesteatoma). Granular myringitis is localized specifically to the eardrum surface.

9. Why is the ear always leaking?
The granulation tissue is highly vascular and "weeps" serum and inflammatory exudate.

10. Can I use over-the-counter drops?
It is strongly advised against. OTC drops (like alcohol or peroxide) can be painful and may delay the healing of the epithelial layer. Always consult an ENT specialist.

8. Summary for Clinicians

Granular myringitis remains a diagnostic challenge due to its mimicry of other chronic otologic conditions. The key to successful management lies in the "Debride, Treat, and Monitor" triad. By ensuring the TM is clear of debris, applying targeted topical corticosteroids/antibiotics, and maintaining a dry ear environment, the clinician can effectively resolve this condition and prevent the need for invasive surgical procedures. Continuous monitoring is vital to ensure that no underlying pathologies, such as cholesteatoma, are masked by the granulation tissue.